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When treated with 17a,20b-dihydroxy-4-pregnen-3-one (17a,20b-DP), a natural maturation-inducing hormone in ®shes,
fully grown zebra®sh oocytes are induced to mature via the activation of the maturation-promoting factor (MPF), which
consists of cdc2 (a catalytic subunit) and cyclin B (a regulatory subunit). In contrast, 17a,20b-DP is unable to induce
growing (previtellogenic and vitellogenic) oocytes to mature. To know the reason growing oocytes fail to mature upon
17a,20b-DP treatment, we investigated changes in the components of machinery responsible for MPF activation during
zebra®sh oogenesis. Immunoblotting experiments using monoclonal antibodies against cdc2, cyclin B, and cdk7 (an
activator of cdc2) have revealed that the concentrations of cdc2 and cdk7 are almost constant during oogenesis. Cyclin
B was present in mature oocytes but absent in growing and fully grown immature oocytes. These results, which are
identical to those in gold®sh, strongly suggest that cyclin B is synthesized from stored (masked) mRNA after 17a,20b-
DP stimulation and that its binding to the preexisting cdc2 allows cdk7 to activate MPF. Microinjection of cyclin B
protein induced MPF activation and germinal vesicle breakdown in growing oocytes, as well as in fully grown oocytes,
indicating that cdk7 present in growing oocytes is already active. Northern blot analysis revealed the presence of cyclin
B mRNA in both previtellogenic and fully grown oocytes. These results indicate that, as in fully grown oocytes, growing
oocytes are already equipped with the catalytic subunit of MPF (cdc2) and its activator (cdk7) and that the appearance
of the regulatory subunit of MPF (cyclin B) is suf®cient for initiating maturation. Therefore, the unresponsiveness of
growing oocytes to 17a,20b-DP is attributable to a de®ciency in the processes leading to cyclin B synthesis, which
include 17a,20b-DP reception on the oocyte surface, subsequent signal transduction pathways, and unmasking the stored
cyclin B mRNA. q 1997 Academic Press
INTRODUCTION by inhibitory phosphorylation of cdc2 on threonine 14/tyro-
sine 15 (T14/Y15) by wee1 and activating phosphorylation
on threonine 161 (T161) by cdk7 (MO15)/cyclin H afterOocyte maturation is ®nally triggered by the maturation-
binding of cdc2 to cyclin B (for review see Coleman andpromoting factor (MPF) in response to stimulation on the
Dunphy, 1994; Solomon, 1994; Morgan, 1995). To date, mo-oocyte surface of the maturation-inducing hormone (MIH)
lecular mechanisms of MPF activation during oocyte matu-secreted from follicle cells (for review see Nagahama et al.,
ration have been investigated in detail for Xenopus (Gautier1995). MPF is a complex of cdc2 (a catalytic subunit) and
and Maller, 1991; Kobayashi et al., 1991; Nebreda et al.,cyclin B (a regulatory subunit), and its activity is controlled
1995) and gold®sh (Hirai et al., 1992a; Kajiura et al., 1993;
Katsu et al., 1993; Yamashita et al., 1995). Immature Xeno-
pus oocytes contain cyclin B-bound inactive cdc2 (pre-MPF)1 Present address: Department of Biology, Faculty of Fisheries,
that is phosphorylated on both T14/Y15 and T161. MIHHokkaido University, Hakodate 041, Japan.
(progesterone) signal activates cdc25, which dephosphory-2 To whom correspondence should be addressed. Fax: 81-11-757-
5994. E-mail: myama@bio.hokudai.ac.jp. lates T14/Y15 and yields cyclin B-bound active cdc2 phos-
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phorylated only on T161. How MIH stimulates cdc25 phos- nents of MPF itself or its regulatory machinery such as
cdk7, wee1, and cdc25, but that it is due to a de®ciencyphatase activity is completely unknown, although transla-
tion of the c-mos gene product (Sagata et al., 1988, 1989; in events leading to cyclin B mRNA translation.
Yew et al., 1992; Matten et al., 1996; Roy et al., 1996) and
cyclin-like proteins (Nebreda et al., 1995) is reported to be
necessary for initiating oocyte maturation in Xenopus. MATERIALS AND METHODS
In striking contrast to Xenopus, in which pre-MPF is
present in immature oocytes, immature gold®sh oocytes Oocyte Extraction
contain monomeric cdc2, and cyclin B is absent (Kajiura
Zebra®sh (Danio rerio) were cultured at 28.57C in our laboratory.et al., 1993). MIH (17a,20b-dihydroxy-4-pregnen-3-one,
Under a binocular microscope, oocytes were manually isolated17a,20b-DP) stimulates translation of cyclin B mRNA
from ovaries with ®ne forceps in zebra®sh Ringer's solution (116
stored in immature oocytes (Hirai et al., 1992a). The syn- mM NaCl, 2.9 mM KCl, 1.8 mM CaCl2, 5 mM Hepes, pH 7.2). The
thesized cyclin B protein binds to the preexisting cdc2, oocytes were classi®ed into ®ve stages according to their diameters
which enables cdk7 to phosphorylate cdc2 on T161. The (stage 1, 180±300 mm; stage 2, 300±430 mm; stage 3, 430±550 mm;
resulting cyclin B-bound cdc2 phosphorylated on T161 is stage 4, 550±670 mm; stage 5, ⁄ 670 mm). Stage 1 oocytes are
active and promotes all the changes accompanying oocyte previtellogenic, stage 2±4 oocytes are vitellogenic, and stage 5 oo-
cytes are fully grown (Selman et al., 1993). The isolated oocytesmaturation such as germinal vesicle breakdown (GVBD),
(ca. 1 ml) were washed three times in ice-cold extraction buffer (EB:chromosome condensation and spindle formation. Inhibi-
100 mM b-glycerophosphate, 20 mM Hepes, 15 mM MgCl2, 5 mMtory phosphorylation of cyclin B-bound cdc2 by wee1 and
EGTA, 1 mM dithiothreitol, 100 mM (p-amidinophenyl)methanes-subsequent dephosphorylation by cdc25, which take
ulfonyl ¯uoride, 3 mg/ml leupeptin, pH 7.5), and after removingplace during Xenopus oocyte maturation, are not involved
excess EB with ®lter paper, 20 ml of new EB was added. The oocytes
in MPF activation during gold®sh oocyte maturation (Ya- were homogenized with a pestle (Pellet Pestle; Kontes) and centri-
mashita et al., 1995). Arti®cial introduction of cyclin B fuged at 15,000g for 10 min at 47C. The supernatant (20 ml) was
protein into immature gold®sh oocytes induces GVBD collected and mixed with 20 ml of sample buffer containing 125
without any protein synthesis (Katsu et al., 1993). There- mM Tris±HCl (pH 6.8), 4% sodium dodecyl sulfate (SDS), and 10%
fore, the onset of cyclin B mRNA translation triggered by 2-mercaptoethanol. To examine the state of cdc2 and cyclin B dur-
ing oocyte maturation, immature and mature oocytes were ex-MIH stimulation is required and suf®cient for initiating
tracted and subjected to suc1 precipitation, as described previouslyoocyte maturation in this species. The absence of pre-
(Yamashita et al., 1992a).MPF has also been demonstrated in immature oocytes of
other ®shes (carp, loach, cat®sh, lamprey) and amphibians
(Rana and Bufo) except Xenopus (Tanaka and Yamashita, Induction of Oocyte Maturation
1995), suggesting that similar mechanisms of MPF activa-
Oocyte maturation was induced in vitro by incubating manuallytion are adopted in these species. Taken together, these
isolated fully grown oocytes in zebra®sh Ringer's solution con-studies have clearly shown the existence of species-spe-
taining 1 mg/ml of 17a,20b-DP. Maturational processes were as-ci®c mechanisms of MPF activation during oocyte matu-
sessed by treating oocytes with a clearing solution (5% Formalinration, in spite of the generality of MPF structure and
and 4% acetic acid in Ringer), which facilitates the microscopicfunction (for review see Kishimoto, 1988; Masui, 1992).
examination of the occurrence of GVBD.Although fully grown oocytes mature in response to
MIH by the mechanisms described above, it is well known
that growing (previtellogenic and vitellogenic) oocytes Measurement of Cytoplasmic Volume of Each Stage
cannot respond to MIH. Since injection of active MPF of Oocytes
into growing oocytes can induce GVBD (Sadler and
Oocytes were centrifuged (10,000g, 10 min, 47C) in a densityMaller, 1983; Taylor and Smith, 1987; Rime et al., 1991),
gradient made by centrifuging 40% Ficoll 400 (Pharmacia) in zebra-the failure of growing oocytes to mature by MIH treat-
®sh Ringer's solution at 10,000g for 10 min. The centrifugationment must be due to a de®ciency in the mechanisms prior
segregated the cytoplasm including germinal vesicle from the meta-
to MPF action (see also review by Masui and Clarke, plasm (yolk and cortical alveoli) without breaking the cytoplasmic
1979). Using zebra®sh as an experimental model, we have membrane (cf. Fig. 3). The volume of cytoplasm was calculated
investigated which portions of the mechanisms are not mathematically from the length of the axis occupied by the cyto-
yet established in growing oocytes. We show here that plasm.
growing ®sh oocytes contain similar concentrations of
cdc2 and cdk7 proteins and cyclin B mRNA to those in
Production of Gold®sh Cdc2 and Cdk7 Proteinsfully grown oocytes and that, as in fully grown oocytes,
injection of a recombinant cyclin B protein or in vitro A prokaryotic expression vector for gold®sh cdc2 fused at its
transcribed cyclin B mRNA induces GVBD in growing N-terminus with glutathione S-transferase (GST) was constructed
oocytes through the activation of cdc2. These results sug- as follows. A cDNA encoding full-length gold®sh cdc2 (Kajiura et
gest that the unresponsiveness of growing ®sh oocytes to al., 1993) was ampli®ed by polymerase chain reaction (PCR) with
two oligonucleotide primers, 5*-CCGAATTCCAGATCTGAT-MIH stimulation is not due to a de®ciency in the compo-
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GGATGACTATCTGAAGATAGAG-3* (5* primer introducing cyclin B protein to activate cdc2 varies according to batches of the
preparation, probably due to differences in the ef®ciency of refold-EcoRI site) and 5*-GCGTCGACATCGATATCTATATCTTCA-
GGTTACTGGCTGG-3* (3* primer introducing SalI site). The ing of the protein after electroelution from the gel, we ®rst deter-
mined the dose necessary for activating cdc2 in vitro. ExperimentsPCR product was digested with EcoRI and SalI and ligated
into EcoRI/SalI-digested pGEX-KG (Guan and Dixon, 1991). Simi- using a cell-free system derived from immature gold®sh oocytes
(Hirai et al., 1992a) have shown that the minimum concentrationlarly, the expression vector for GST±gold®sh cdk7 was con-
structed from a cDNA encoding full-length gold®sh cdk7 (Onoe of the recombinant cyclin B used in this study necessary for induc-
ing the activation of cdc2 is 20 mg/ml. Zebra®sh oocytes were,et al., 1993) with the oligonucleotide 5*-GGGAATTCATATGGC-
ATTAGATGTGAAATCC-3* (5* primer introducing EcoRI site) therefore, injected with 1/50 vol of 1 mg/ml gold®sh cyclin B. As
a control, the same concentration of bovine serum albumin (BSA)and 5*-GCGTCGACATCGATATCAGAAAACCAGTTTCTTT-
TTAAG-3* (3* primer introducing SalI site). was injected. The injected oocytes were cultured for 2 hr in the
presence of 10 mg/ml cycloheximide and then ®xed in a clearingGST±gold®sh cdc2 and cdk7 proteins were expressed in Esche-
richia coli TB1 and puri®ed by SDS±polyacrylamide gel electropho- solution to examine the occurrence of GVBD. Some oocytes were
®xed in Bouin's solution, embedded in paraf®n, sectioned at 10resis (PAGE), followed by electroelution in Tris±glycine buffer
without SDS, as described previously (Hirai et al., 1992a). The puri- mm, and examined under a light microscope after staining with
hematoxylin and eosin.®ed proteins were dialyzed against distilled water, lyophilized, and
weighed to use as standards for calculating the protein content of Cyclin B mRNA was produced in vitro using a cDNA encoding
full-length gold®sh cyclin B (Hirai et al., 1992a) as a template, bycdc2 and cdk7 in oocytes with the aid of immunological tech-
niques, as described below. means of an mCAP mRNA capping kit (Stratagene), as described
previously (Katsu et al., 1995). The in vitro transcribed mRNA
was injected into oocytes at a ®nal concentration of 2 mg/ml. The
injected oocytes were cultured for 2 hr in the absence of cyclohexi-Immunological Detection of Cyclin B, Cdc2, and
mide, and the occurrence of GVBD was examined.Cdk7 in Zebra®sh Oocytes
Proteins cyclin B, cdc2, and cdk7 in zebra®sh oocytes were de- Measurement of Kinase Activitytected by immunoblotting. Monoclonal antibodies raised against a
recombinant gold®sh cyclin B (B112, Katsu et al., 1993) and the C- The cdc2 kinase activity was measure with a synthetic peptide
terminal peptide sequence of gold®sh cdc2 (GFC3-9, Kajiura et al., (SP peptide, KKAAKSPKKAKK), which is speci®cally phosphory-
1993) were used for detecting zebra®sh cyclin B and cdc2, respec- lated by cdc2 and its related kinase, cdk2 (Hirai et al., 1992b),
tively. To detect cdk7, we produced new monoclonal antibodies according to the procedure described previously (Yamashita et al.,
against gold®sh cdk7 by immunizing mice with GST±gold®sh cdk7 1992b). Brie¯y, oocyte extracts (5 ml) were incubated for 10 min at
according to the procedures described previously (Yamashita et al., 307C, and the peptide was absorbed onto P81 phosphocellulose pa-
1991). To obtain antibodies speci®c to cdk7, clones were screened per (Whatman). After washing in phosphoric acid, the radioactivity
with cdk7 cleaved from GST with thrombin (Guan and Dixon, remaining on the paper was measured by Cherenkov counting.
1991). One clone (GFK7-49, IgG2b with a k light chain) was selected
to detect zebra®sh cdk7. Isolation of Zebra®sh Cyclin B cDNA
Proteins derived from 180 nl of oocytes in stages 2±5 were ap-
Zebra®sh cyclin B cDNA was obtained by reverse transcription±plied onto the gel. For stage 1 oocytes, proteins from 90 nl of oocytes
PCR (RT±PCR). Total RNA was isolated by homogenizing thewere applied, due to the dif®culty in isolating this stage of oocytes
zebra®sh ovary in Isogen (Nippon Gene) according to manufactur-manually. The numbers of oocytes corresponding to the volume
er's instructions. Single-strand cDNA was synthesized using theapplied on the gel were 12.5, 7, 3, 1.5, and 1 for stages 1±5, respec-
Superscript Preampli®cation System (Gibco BRL) with oligo(dT)12±18tively. Proteins were electrophoresed on 12.5% polyacrylamide gels
primer. PCR was 30 cycles of 947C for 1 min, 557C for 1 min,and electroblotted on Immobilon membrane (Millipore). After
and 727C for 2 min, using two degenerate oligonucleotides con-blocking with 5% nonfat dry milk, the blots were probed with the
taining an EcoRI recognition site at the 5* end; 5* primer, 5*-CGG-monoclonal antibodies as described previously (Yamashita et al.,
GAATTCTSTGYCARGCNTTCTCYGATG, and 3* primer, 5*-1992a).
CGGGAATTCGMRTACTTGTTCYTNAYAG (M  A / C, R The protein contents of cdc2 and cdk7 were determined by quan-
A / G, S  C / G, Y  C / T, N  A / C / G / T, EcoRItifying the density of the immunoreactive bands with NIH Image
site is underlined). The 5* and 3* primers correspond to the highly(Macintosh), using E. coli-produced gold®sh cdc2 (1±5 ng) and cdk7
conserved amino acid sequences in cyclin B, LCQAFSD and TVK-(0.2±2 ng) as standards. The concentrations of cdc2 and cdk7 in
NKYA, respectively. The obtained PCR product (ca. 800 bp) wasthe oocytes were then calculated by dividing the protein content
digested with EcoRI, ligated into EcoRI-cut pBluescript II (SK) (Stra-by the cytoplasmic volume of each stage of oocytes measured, as
tagene), and sequenced. At the amino acid level, the cDNA frag-described above.
ment shows 92% homology to gold®sh cyclin B (Hirai et al., 1992a)
but only 38% to gold®sh cyclin A (Katsu et al., 1995). We therefore
refer to this fragment as zebra®sh cyclin B cDNA (DDBJ/EMBL/Microinjection of Gold®sh Cyclin B into Zebra®sh
GenBank Accession No. AB000218).Oocytes
Full-length gold®sh cyclin B protein was produced in E. coli BL21 Synthesis of Zebra®sh Cyclin B mRNA and
(DE3), puri®ed by electroelution following SDS±PAGE, and al- Northern Blottinglowed to recover the native three-dimensional structure during a
dialysis against 1 mM Hepes (pH 7.0), as described previously (Hirai The vector containing the zebra®sh cyclin B cDNA was digested
with either BamHI (for sense RNA) or XhoI (for antisense RNA).et al., 1992a; Katsu et al., 1993). As the potency of the recombinant
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each stage of oocyte were immunoblotted with monoclonal
antibodies against cdc2 and cdk7 (Fig. 2A), and the content
was measured using recombinant cdc2 and cdk7 as stan-
dards. The values obtained were divided by the number of
oocytes applied on the gel, yielding the protein content of
cdc2 and cdk7 per oocyte. Both cdc2 and cdk7 increased
during oogenesis (Fig. 2B). During oogenesis, however, the
oocyte volume also greatly increased (ca. 7 nl in stage 1
to 180 nl in stage 5). We then examined changes in the
FIG. 1. Anti-cdc2 and anti-cyclin B immunoblots of suc1 precipi- concentration of cdc2 and cdk7 during oogenesis. In addi-
tates from immature (I) and mature (M) zebra®sh oocyte extracts. tion to the increase in cytoplasm, the oocyte volume in-
The positions of protein markers are shown on the left. Cyclin B creased as a result of the accumulation of metaplasm
forming a complex with cdc2 is found only in mature oocytes.
mainly consisting of yolk and cortical alveoli, in which
neither cdc2 nor cdk7 is present. To determine the accurate
concentrations of cdc2 and cdk7 in the oocytes, therefore,
we must know the volume of oocytes excluding the meta-Sense RNA was synthesized by T7 RNA polymerase. Antisense
plasm. Thus, oocytes were centrifuged on a density gradientRNA was synthesized by T3 RNA polymerase in the presence of
digoxigenin (DIG)-labeled UTP (Boehringer). of Ficoll, which segregated the cytoplasm, including the
Cyclin B mRNA was detected by Northern blotting with the germinal vesicle, from the yolk and cortical alveoli (Figs.
DIG-labeled antisense RNA as a probe, and its content was esti- 3A and 3B). The cytoplasmic volume thus obtained was
mated using the sense RNA for a standard. Total RNA (5 mg) iso- 4.33 { 0.21, 12.75 { 0.72, 25.63 { 2.91, 30.23 { 2.47, and
lated from the oocytes in stages 1 and 5 and the cyclin B sense 44.03 { 2.71 nl in stage 1±5 oocytes, respectively (mean
RNA (1, 10, and 100 ng) were electrophoresed in a 1% agarose gel { standard deviations for ®ve independent measurements).containing 6% formaldehyde and blotted onto a nylon membrane
The protein contents obtained from immunoblotting exper-(Hybond N/, Amersham). The blots were hybridized with the DIG-
iments (Fig. 2B) were divided by the cytoplasmic volume tolabeled cyclin B antisense RNA, and the hybridized probe was visu-
calculate the concentrations of cdc2 and cdk7 in the oocytesalized with alkaline phosphatase-conjugated anti-DIG antibody
excluding the metaplasm. The concentrations were stable(Boehringer).
during oogenesis, and previtellogenic oocytes already con-
tained concentrations of cdc2 and cdk7 similar to those in
RESULTS fully grown oocytes (Fig. 2C).
Absence of Pre-MPF in Immature Zebra®sh
Induction of GVBD in Growing Oocytes byOocytes
Microinjection of Cyclin B Protein
Information about molecular mechanisms of MPF activa-
The immunoblotting experiments revealed that, as intion during oocyte maturation is lacking for zebra®sh, al-
fully grown oocytes, previtellogenic and vitellogenic oo-though we have already suggested that the mechanisms em-
cytes contain cdc2 (the catalytic subunit of MPF) and cdk7ployed in gold®sh are ubiquitous among ®shes and amphibi-
(the cdc2 activating kinase) but not cyclin B (the regulatoryans except Xenopus (Tanaka and Yamashita, 1995). We ®rst
subunit of MPF). After binding to cyclin B, cdc2 is activatedexamined whether fully grown immature zebra®sh oocytes
by cdk7 through phosphorylation on T161. The activationcontain pre-MPF, since the absence of pre-MPF is the most
of cdk7 itself requires a regulatory subunit, cyclin H (Fisherremarkable characteristic that distinguishes the mecha-
and Morgan, 1994). Since no antibodies recognizing ®shnisms in gold®sh from those in Xenopus. Extracts from
cyclin H are available, we cannot examine the presence ofimmature and mature oocytes were subjected to suc1 pre-
cyclin H in zebra®sh oocytes. However, it is possible tocipitation, which precipitates cyclin B-bound cdc2 as well
examine whether cdk7 is active in the oocytes by microin-as monomeric cdc2. The suc1 precipitates from mature oo-
jecting cyclin B protein into the oocytes. If cdk7 is active,cytes contained both cdc2 and cyclin B, whereas those from
it can activate cdc2, forming a complex with the injectedimmature oocytes contained only cdc2 (Fig. 1). These re-
cyclin B, which promotes GVBD in the injected oocytes, assults clearly indicate the absence of pre-MPF in immature
we have already demonstrated in fully grown gold®sh oo-zebra®sh oocytes, strongly suggesting that the zebra®sh em-
cytes (Katsu et al., 1993).ploys mechanisms of MPF activation similar to those for
We examined whether the introduction of cyclin B pro-gold®sh.
tein into immature zebra®sh oocytes induces GVBD (Table
1). Similar to gold®sh, microinjection of E. coli-produced
Changes in Protein Levels of Cdc2 and Cdk7 cyclin B protein in fully grown zebra®sh oocytes induced
during Zebra®sh Oogenesis GVBD in the presence of cycloheximide (Figs. 4A and 4B).
Cyclin B-induced GVBD occurred much earlier thanWe examined changes in the protein content of cdc2 and
cdk7 during zebra®sh oogenesis. Proteins extracted from 17a,20b-DP-induced GVBD (Fig. 5), indicating that the in-
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FIG. 3. Previtellogenic (A) and fully grown (B) oocytes centrifuged
on a Ficoll density gradient. The centrifugation segregated the cyto-
plasm (CY), including the germinal vesicle, from the metaplasm
which consists mainly of cortical alveoli (CA) in previtellogenic
stage 1 oocytes and yolk (Y) in fully grown stage 5 oocytes. Scale,
100 mm.
troduction of cyclin B protein bypasses the early processes
promoted by 17a,20b-DP. Microinjection of cyclin B pro-
tein induced GVBD even in previtellogenic and vitellogenic
oocytes (Figs. 4C and 4D, Table 1).
To con®rm that cyclin B-induced GVBD is due to the
activation of cdc2, we measured cdc2 kinase activity in
cyclin B-injected oocytes (Fig. 6). Cyclin B-injected previtel-
logenic and fully grown oocytes and 17a,20b-DP-treated
fully grown oocytes, all of which underwent GVBD, exhib-
ited high cdc2 kinase activity, whereas BSA-injected previ-
tellogenic and fully grown oocytes and 17a,20b-DP-treated
previtellogenic oocytes, which did not undergo GVBD,
showed little kinase activity.
Presence of Cyclin B mRNA in Previtellogenic
Zebra®sh Oocytes
The microinjection experiments showed that the appear-
ance of cyclin B protein is suf®cient to induce GVBD even in
previtellogenic oocytes, which never undergo GVBD when
treated with 17a,20b-DP. Next, in order to examine
whether cyclin B mRNA exists in previtellogenic zebra®sh
oocytes, we isolated zebra®sh cyclin B cDNA by RT±PCR.
Northern blot analysis using this cDNA as a probe revealed
the presence of cyclin B mRNA in previtellogenic oocytes,
as well as in fully grown oocytes (Fig. 7). Based on the vol-
stages 1±5. The oocyte diameter in each stage is indicated below
the blots. Proteins derived from 90 nl of stage 1 oocytes and 180
nl of stage 2±5 oocytes were applied in each lane. The numbers of
oocytes corresponding to the volume applied on each lane were
12.5, 7, 3, 1.5, and 1 for stages 1±5, respectively. (B) Changes in
the protein content of cdc2 and cdk7 during oogenesis. The protein
content was calculated from the density of the bands of cdc2 and
cdk7 in A, using E. coli-produced cdc2 and cdk7 as standards. Mean
{ standard deviations for three independent measurements. (C)
Changes in the concentration of cdc2 and cdk7 during oogenesis.
FIG. 2. Changes in cdc2 and cdk7 protein levels during zebra®sh The values obtained in B were divided by the cytoplasmic volume
oogenesis. (A) Anti-cdc2 and anti-cdk7 immunoblots of oocytes in of each stage of oocytes. Means { standard deviations (n  3).
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TABLE 1
Induction of GVBD in Zebra®sh Oocytes by Microinjection of Cyclin B
Stage
Injection 1 2 3 4 5
BSA (control) 0/12 (0) 0/20 (0) 0/10 (0) 0/9 (0) 0/15 (0)
Cyclin B protein 19/22 (86) 43/47 (91) 79/80 (99) 22/25 (88) 57/61 (93)
Cyclin B mRNA 13/16 (81) 17/18 (94) 7/8 (88) 15/16 (94) 66/73 (90)
Note. Values are number of oocytes with GVBD/number of oocytes injected. The percentages of GVBD induced are given in parentheses.
ume of cytoplasm, we calculated the concentration of cyclin stimulation. On the other hand, the introduction of cyclin
B protein induces GVBD in oocytes of any stage (TableB mRNA in oocytes. Previtellogenic and fully grown oo-
cytes were found to contain similar concentrations, about 1). These results suggest that cyclin B mRNA stored in
oocytes is masked and unable to be translated until the2 mg/ml, of cyclin B mRNA.
reception of MIH stimulus. To con®rm this, an in vitro
transcribed cyclin B mRNA, which is unlikely to be
Induction of GVBD by Cyclin B mRNA masked, was injected into oocytes at the same concentra-
tion as that of endogenous cyclin B mRNA (2 mg/ml). LikeIn spite of the presence of cyclin B mRNA, neither pre-
vitellogenic nor fully grown oocytes mature until MIH the recombinant cyclin B protein, the in vitro transcribed
FIG. 4. Fully grown (A, B) and previtellogenic (C, D) oocytes microinjected with BSA (A, C) or recombinant cyclin B protein (B, D).
Microinjection of cyclin B protein induced GVBD in both fully grown and previtellogenic oocytes. GV, germinal vesicle. Scale, 100 mm.
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(Dunphy and Kumagai, 1991; Gautier et al., 1991), imma-
ture gold®sh oocytes do not stockpile cyclin B protein, al-
though its mRNA exists. MIH (17a,20b-DP) stimulation on
the oocyte surface initiates translation of cyclin B mRNA
stored in immature oocytes. The synthesized cyclin B pro-
tein binds to the preexisting monomeric cdc2, which en-
ables cdk7, present as an active complex with cyclin H, to
activate MPF by phosphorylating cyclin B-bound cdc2 on
T161. Inhibitory phosphorylation on T14/Y15 by wee1 and
its dephosphorylation by cdc25 after the complex formation
of cdc2 and cyclin B do not occur during gold®sh oocyte
maturation (Fig. 8). When cyclin B protein is injected into
immature gold®sh oocytes, the injected oocytes underwent
GVBD in the absence of any protein synthesis (Katsu et al.,
1993), indicating that the appearance of cyclin B protein
due to the onset of cyclin B mRNA translation in response
to MIH is required and suf®cient for initiating oocyte matu-
ration in gold®sh.
FIG. 5. Kinetics of GVBD induced by 17a,20b-DP (m), cyclin B
protein (l, s), and cyclin B mRNA (j, h). Fully grown oocytes
were injected with cyclin B protein (l) or mRNA (j) and incubated
without 17a,20b-DP. The percentage of GVBD was scored at 10-
min intervals after the injection. To examine the effect of 17a,20b-
DP on the kinetics, we also injected cyclin B protein (s) or mRNA
(h) into the oocytes cultured in the presence of 17a,20b-DP. Cyclin
B protein or mRNA was injected 30 or 40 min after the onset of
17a,20b-DP treatment, respectively, and the percentage of GVBD
was scored at 10-min intervals after the injection.
mRNA induced GVBD irrespective of the stage of oocytes
(Table 1).
GVBD induced by the injection of cyclin B mRNA oc-
curred 80 min earlier than that induced by 17a,20b-DP, but
40 min later than that induced by the injection of cyclin B
protein (Fig. 5). The observed lag between the injections of
cyclin B mRNA and protein (ca. 40 min) probably indicates
the time required for the synthesis of cyclin B protein from
the injected mRNA up to a threshold of MPF activation.
We also examined the kinetics of cyclin B-induced GVBD
in the presence of 17a,20b-DP. Cyclin B protein-induced
GVBD occurred with similar kinetics irrespective of the
presence of 17a,20b-DP, but cyclin B mRNA-induced
GVBD occurred 20 min earlier in the presence of 17a,20b-
DP (Fig. 5). These results indicate that the time required for
the synthesis of cyclin B protein from the injected mRNA
becomes shorter (from 40 to 20 min) when the oocytes are
treated with 17a,20b-DP.
DISCUSSION
Zebra®sh Employs Mechanisms of MPF Activation
Similar to Those for Gold®sh
FIG. 6. Cdc2 kinase activity in previtellogenic (A) and fully grown
Unlike Xenopus, in which oocyte maturation is induced (B) oocytes treated with 17a,20b-DP or injected with BSA or recom-
by cdc25 that dephosphorylates the T14/Y15 of cyclin B- binant cyclin B protein. Hatched columns show the occurrence of
GVBD.bound inactive cdc2 (pre-MPF) present in immature oocytes
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the liberation of the mRNA from its masking proteins under
the in¯uence of 17a,20b-DP. As an initial step in elucidat-
ing molecular mechanisms of unmasking of cyclin B mRNA
upon 17a,20b-DP stimulation, we have isolated a gold®sh
cDNA clone encoding a germ cell-speci®c Y-box protein
and its biological function is now under investigation (Katsu
et al., unpublished), since it is plausible that Y-box proteins
participate in the masking of mRNAs (Matsumoto et al.,
1996).
It is also notable that 17a,20b-DP facilitates the synthesis
FIG. 7. Northern blots of 5 mg of total RNA isolated from previtel- of cyclin B protein from the unmasked mRNA (Fig. 5). This
logenic (P) and fully grown (F) zebra®sh oocytes, as probed with ®nding suggests that 17a,20b-DP also plays an important
DIG-labeled zebra®sh cyclin B antisense RNA. The positions of role in the translational ef®ciency of cyclin B mRNA after
RNA markers are shown on the right. its liberation from masked proteins, in addition to the con-
tribution to the unmasking of cyclin B mRNA. The most
likely event involved in the 17a,20b-DP-enhanced transla-
tion is cytoplasmic polyadenylation of mRNA, which takesWe have shown here the existence of similar situations
place on speci®c mRNAs during oocyte maturation, fertil-in zebra®sh, i.e., the absence of pre-MPF in immature oo-
ization, and early embryogenesis (for review see Hake andcytes (Fig. 1) and the induction of GVBD by microinjection
Richter, 1997). We have recently investigated the state ofof cyclin B protein into immature oocytes in the presence
polyadenylation of cyclin B mRNA during gold®sh oocyteof cycloheximide (Fig. 4 and Table 1). It is therefore most
maturation and found that its apparent polyadenylationlikely that the zebra®sh employs mechanisms of MPF acti-
(about 100 bases long) occurs only after the activation ofvation similar to those in gold®sh, in which all components
MPF. We have also noticed, however, that 17a,20b-DP isnecessary for MPF activation except cyclin B protein are
unable to mature the oocytes treated with cordycepin, anpresent in fully grown immature oocytes, and that MIH
inhibitor of polyadenylation (Katsu et al., unpublished).stimulates the synthesis of cyclin B protein, the only com-
These results suggest that a short elongation of the poly(A)ponent necessary for oocyte maturation.
tail of cyclin B mRNA is necessary for its translational acti-The mechanisms by which MIH induces the translation
vation, although the apparent elongation of the poly(A) tailof cyclin B mRNA remain to be elucidated. We have shown
is not required. Detailed investigations of the polyadenyla-here that when injected into oocytes the in vitro transcribed
tion state of the mRNA injected into 17a,20b-DP-treatedunmasked cyclin B mRNA can induce GVBD in the absence
or untreated oocytes should provide information about theof 17a,20b-DP, demonstrating that the presence of un-
mechanisms of translational activation of cyclin B mRNAmasked cyclin B mRNA in the oocyte is suf®cient for induc-
by 17a,20b-DP.ing oocyte maturation. It is most probable that the transla-
tional activation of stored cyclin B mRNA is induced by Consistent with the difference in the mechanisms of MPF
FIG. 8. Molecular mechanisms of MPF activation during ®sh oocyte maturation. T, threonine 161. See text for details.
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activation between Xenopus and ®sh, microinjection of 20% of that in fully grown oocytes, the KD for binding of
the steroid to the receptor is the same in growing and fullycyclin B protein into growing oocytes exhibited different
results between the two species. Injection of cyclin B pro- grown oocytes. In addition, they showed that the coupling
between the receptor and adenylate cyclase, the activity oftein or mRNA caused GVBD in growing, as well as fully
grown, ®sh oocytes (this study). Growing Xenopus oocytes, which decreases in response to progesterone, is intact in
small oocytes. They therefore concluded that the inabilityhowever, do not undergo GVBD even when injected with
cyclin B (Rime et al., 1995), although fully grown oocytes of growing oocytes to mature in response to progesterone
is not at the levels of the receptor and subsequent adenylateundergo GVBD upon cyclin B injection (Swenson et al.,
1986; Murray et al., 1989). The difference between gold®sh cyclase. Contrary to this view, positive correlations be-
tween the increase in MIH receptor density and the en-and Xenopus is attributable to the difference in the activi-
ties of wee1 and cdc25. In growing Xenopus oocytes, the hanced ability of the oocytes to respond to MIH during
oogenesis and oocyte maturation have been reported forwee1 activity surpasses the cdc25 activity, so that the in-
jected cyclin B forms a complex with cdc2, but the resulting Xenopus (Liu and PatinÄ o, 1993) and ®sh (PatinÄ o and
Thomas, 1990; Thomas and PatinÄ o, 1991). In addition, Jor-cyclin B-bound cdc2 is immediately phosphorylated on Y15
by wee1 and thereby remains inactive (Rime et al., 1995). dana et al. (1982) have reported stage-dependent changes
in the ability of progesterone to inhibit adenylate cyclaseOn the other hand, since the wee1 activity is negligible in
®sh oocytes, the complex formation of injected cyclin B and activity of Xenopus oocytes. These ®ndings suggest that the
inability of growing oocytes to mature in response to MIHpreexisting cdc2 leads directly to MPF activation without
inhibitory phosphorylation by wee1 (Yamashita et al., is dependent on the insuf®ciency of the MIH receptor and
subsequent events including changes in adenylate cyclase1995).
activity. To verify the involvement of the receptor in the
unresponsiveness of growing oocytes to MIH, we must
Why Growing Zebra®sh Oocytes Cannot Mature know the molecular nature of the MIH receptor and carry
by MIH out detailed investigations into both quantitative and
qualitative changes in the MIH receptor molecule duringFully grown zebra®sh oocytes can respond to 17a,20b-
DP, while growing (previtellogenic and vitellogenic) oocytes oogenesis.
Recently, the inability of growing Xenopus oocytes tocannot. Immunoblotting and Northern blotting experi-
ments (Figs. 2 and 7) have shown that growing zebra®sh MIH (progesterone) has been suggested to be partly due to
the activity of protein phosphatase 2A, which positivelyoocytes contain comparable concentrations of cdc2 and
cdk7 proteins and of cyclin B mRNA to those in fully grown regulates the activity of wee1, thereby keeping pre-MPF
inactive in growing Xenopus oocytes (Rime et al., 1995). Inoocytes, although cyclin B protein is absent, as in fully
grown oocytes. Furthermore, it has been demonstrated that contrast, the acquisition of the competence to mature when
mouse oocytes are isolated from follicle cells has been re-the introduction of cyclin B protein or in vitro transcribed
cyclin B mRNA can induce GVBD in growing oocytes as ported to coincide with the increase in the cdc2 protein
level in oocytes (Chesnel and Eppig, 1995; de VanteÂry et al.,well as in fully grown oocytes (Fig. 4 and Table 1). The
presence of cdc2 and cdk7 proteins and cyclin B mRNA and 1996; Mitra and Schultz, 1996). The molecular mechanisms
of MPF activation during oocyte maturation vary from spe-the occurrence of cyclin B-induced GVBD have also been
observed in growing gold®sh oocytes (our unpublished cies to species (mouse, Hampl and Eppig, 1995; pig, Naito
et al., 1995; bovine, LeÂvesque and Sirard, 1996; Xenopus,data). These ®ndings suggest that the components of MPF
and its regulatory machinery, including wee1, cdc25, and Nebreda et al., 1995; gold®sh, Yamashita et al., 1995; star-
®sh, Okumura et al., 1996). It is, therefore, likely that thecdk7, are essentially unchanged during oogenesis and that
the reason growing oocytes cannot mature upon MIH stim- reason for the unresponsiveness of growing oocytes to the
MIH signal is also different according to species. Unlike theulation is due to the failure of synthesis of cyclin B protein
from its mRNA stored in oocytes. cases of Xenopus and the mouse, the inability of growing
oocytes to mature upon MIH treatment in ®shes and am-Why then does cyclin B mRNA fail to be translated in
growing oocytes? One possibility is the absence or scanti- phibians except Xenopus does not seem to be dependent on
a de®ciency in the components of MPF or regulatory kinasesness of the MIH receptor on the surface of growing oocytes.
The existence of the MIH receptor on the oocyte surface and phosphatases such as wee1 and cdc25, since the concen-
trations of cdc2 and cdk7 remain essentially the same dur-has been demonstrated by speci®c binding of labeled ligand
to membrane fractions obtained from fully grown oocytes ing oogenesis and the introduction of cyclin B induces
GVBD in any stage of oocytes. It is most likely that growingof the frog (Kostellow et al., 1982; Sadler and Maller, 1982;
Liu and PatinÄ o, 1993), star®sh (Yoshikuni et al., 1988), and oocytes of these species have not yet been equipped with
the mechanisms that initiate cyclin B mRNA translation®sh (Maneckjee et al., 1989, 1991; PatinÄ o and Thomas,
1990; Yoshikuni et al., 1993; King et al., 1997). However, upon MIH stimulation. The mechanisms of the initiation
of cyclin B mRNA translation, in which unmasking of thethe molecular nature of the MIH receptor is still unknown.
Sadler and Maller (1983) have reported that although the mRNA and subsequent chemical modi®cations, including
polyadenylation, should be involved are completely un-density of the receptor in growing Xenopus oocytes is only
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inhibition by progesterone of the adenylate cyclase of oocytesknown. Further studies on the chemical nature of the MIH
and follicle cells of Xenopus laevis. FEBS Lett. 143, 124±128.receptor and the mechanisms of unmasking of cyclin B
Kajiura, H., Yamashita, M., Katsu, Y., and Nagahama, Y. (1993).mRNA after the reception of the MIH signal are indispens-
Isolation and characterization of gold®sh cdc2, a catalytic compo-able for understanding the molecular mechanisms of the
nent of maturation-promoting factor. Dev. Growth Differ. 35,initial phase of oocyte maturation upon MIH stimulation,
647±654.
as well as for understanding the reason growing oocytes Katsu, Y., Yamashita, M., Kajiura, H., and Nagahama, Y. (1993).
cannot mature when treated with MIH. Behavior of the components of maturation-promoting factor,
cdc2 and cyclin B, during oocyte maturation of gold®sh. Dev.
Biol. 160, 99±107.
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